Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Asset disposition
Inv. presentation
Acq. announced
OPKO HEALTH, INC. (OPK) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 8-K Quarterly results
08/03/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: " "
06/30/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
05/19/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/08/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate"
02/23/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results"
02/10/2023 8-K Quarterly results
01/03/2023 8-K Other Events  Interactive Data
11/08/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results"
08/16/2022 8-K Quarterly results
08/05/2022 8-K Quarterly results
07/15/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
04/27/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/20/2022 8-K Other Events  Interactive Data
02/24/2022 8-K Quarterly results
01/24/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/18/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AGREEMENT AND PLAN OF MERGER AND REORGANIZATION",
"SHAREHOLDER AGREEMENT"
10/28/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "OPKO Health Reports 2021 Third Quarter Business Highlights and Financial Results"
09/03/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amended and Restated Credit Agreement, by and among by and among BioReference Laboratories, Inc., certain of its subsidiaries, and JPMorgan Chase Bank, N.A"
07/29/2021 8-K Quarterly results
07/12/2021 8-K Quarterly results
06/25/2021 8-K Quarterly results
06/23/2021 8-K Quarterly results
06/21/2021 8-K Quarterly results
05/21/2021 8-K Quarterly results
05/07/2021 8-K Quarterly results
04/28/2021 8-K Quarterly results
03/17/2021 8-K Quarterly results
03/03/2021 8-K Quarterly results
02/22/2021 8-K Quarterly results
02/18/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy